Item 7.01. Regulation FD Disclosure.

Biomea Fusion, Inc. (the "Company") from time to time presents and/or distributes to the investment community at various industry and other conferences slide presentations to provide updates and summaries of its business. On January 12, 2022, the Company will present an updated corporate presentation virtually at the 40th Annual J.P. Morgan Healthcare Conference and post the presentation in the "Investors & Media" portion of its website at www.biomeafusion.com. A copy of the Company's current corporate slide presentation is attached to this Current Report on Form 8-K as Exhibit 99.1. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

The information contained in Item 7.01 of this Form 8-K (including Exhibit 99.1 attached hereto) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits



Exhibit
Number       Description

99.1           Corporate Slide Presentation of Biomea Fusion, Inc. dated January 2022

104          Cover Page Interactive Data File (embedded within the Inline XBRL document)




                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses